Dr Mark Jay Spector, DPM | |
3112 N Jupiter Rd, Ste. 213 A, Garland, TX 75044-6578 | |
(972) 530-4655 | |
(972) 495-9500 |
Full Name | Dr Mark Jay Spector |
---|---|
Gender | Male |
Speciality | Podiatry |
Experience | 49 Years |
Location | 3112 N Jupiter Rd, Garland, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1982639886 | NPI | - | NPPES |
018658701 | Medicaid | TX |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
213ES0131X | Podiatrist - Foot Surgery | 1034 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Mark Jay Spector, DPM 3112 N Jupiter Rd, Ste. 213 A, Garland, TX 75044-6578 Ph: (972) 530-4655 | Dr Mark Jay Spector, DPM 3112 N Jupiter Rd, Ste. 213 A, Garland, TX 75044-6578 Ph: (972) 530-4655 |
News Archive
The creation of a network of centres of reference and adopting measures that promote research and access to treatments are two key aspects for improving the prognosis of patients with soft tissue sarcoma (STS), an uncommon type of cancer that originates in the tissues that connect, support and surround other body structures, such as muscles, fat, blood vessels, nerves, tendons and lining of the joints.
Nivolumab has been approved since April 2016 as a checkpoint inhibitor for the treatment of adults with locally advanced or metastatic nonsquamous non-small-cell lung cancer (NSCLC) who have already undergone chemotherapy.
The Chamber's President and CEO Thomas Donohue vowed first and foremost to fight against the overhaul's employer mandate, but noted that in other cases the organization will work to fix flaws rather than repeal the measure.
MedAssets, Inc. today announced that it has renewed and expanded its spend management agreement with Scripps Health, an award-winning integrated healthcare delivery network based in San Diego, California. MedAssets will continue to provide its spend management solutions including group purchasing services, supply chain data and analytics tools and physician preference item consulting services for implantable medical devices.
Now, based on the final results of a nationwide study led by UCLA, clinicians may be able to accurately predict within a week whether a particular drug will be effective by using a non-invasive test that takes less than 15 minutes to administer. The test will allow physicians to quickly switch patients to a more effective treatment, if necessary.
› Verified 1 days ago
Dr. Robert Jeffrey Doyle, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 6550 Naaman Forest Blvd, Suite 200, Garland, TX 75044 Phone: 972-480-0072 Fax: 972-480-0073 | |
North Texas Foot And Ankle, Pa Podiatrist Medicare: Medicare Enrolled Practice Location: 2020 N Glenbrook Dr, Garland, TX 75040 Phone: 972-530-3000 Fax: 214-369-6259 | |
North Star Foot And Ankle Associates, Pa Podiatrist Medicare: Medicare Enrolled Practice Location: 6550 Naaman Forest Blvd Ste 200, Garland, TX 75044 Phone: 972-480-0072 Fax: 972-480-0073 | |
Hannah Christine Abigail, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 7606 Covewood Dr, Garland, TX 75044 Phone: 972-207-2852 | |
Kirubel Gebresenbet, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2910 Broadway Blvd Ste 212, Garland, TX 75041 Phone: 619-342-6199 | |
Dr. Hung Aden Huynh, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 6550 Naaman Forest Blvd Ste 200, Garland, TX 75044 Phone: 972-480-0072 Fax: 972-480-0073 | |
Charles William Siebert Jr., DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2829 Saturn Road, Suite 101, Garland, TX 75041 Phone: 972-278-2145 Fax: 972-278-0294 |